Oprah Winfrey reveals taking GLP-1 weight-loss | Gossip Wire

Trending

Oprah Winfrey reveals taking GLP-1 weight-loss…

Oprah Winfrey says taking a GLP-1 drug reminiscent of Ozempic and Wegovy has modified her total perspective on “thin people.”

The media icon, 70, took to her podcast final week to share her expertise with an undisclosed kind of GLP-1 drug that she started taking in 2023.

A sort 2 diabetes treatment that may additionally support in weight loss, GLP-1 scripts embrace the well-known names Ozempic and Wegovy.

While discussing the use, security and efficacy of GLP-1 medicine with Dr. Ania Jastreboff on the Jan. 14 episode of “The Oprah Podcast,” the Harpo Productions founder mentioned her total manner of excited about how “thin” people method food was all incorrect.

Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and affiliate professor on the Yale School of Medicine, to speak in regards to the new GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound. YouTube/Oprah

“One of the things that I realized the very first time I took a GLP-1 was that all these years I thought that thin people — those people — had more willpower,” Winfrey instructed Dr. Jastreboff, including that she believed, “They ate better foods. They were able to stick to it longer. They never had a potato chip.”

However, after beginning on a GLP-1, Winfrey got here to consider that “willpower” was in reality an absence of intrusive starvation ideas, which is commonly referred to as “food noise.”

“And then I realized the very first time I took the GLP-1 that, they’re not even thinking about it,” the Oscar-winner mentioned of “thin people” and food.

“They’re eating when they’re hungry and they’re stopping when they’re full.”

Oprah mentioned her perspective on “thin people” modified after taking a GLP-1 drug. oprahdaily/Instagram

The Harpo Productions founder used to suppose that “thin people” simply had “more willpower.” oprahdaily/Instagram

That mindset “doesn’t work if you have obesity,” Winfrey added.

While discussing how weight problems is a illness, Winfrey additionally shared how her struggles with weight loss performed out within the public eye and took a toll on her.

“Every week [I was] exploited by the tabloids,” she mentioned, referring to the years she spent internet hosting her hit daytime talkshow. “Anytime any comedian wanted to make fun or make a joke about it, they would make a joke about it. And I accepted it because I thought I deserved it.”

Oprah Winfrey attends a premiere for the movie “The Six Triple Eight”, at The Egyptian Theatre Hollywood in Los Angeles, California., December 3, 2024. REUTERS

The media queen additionally confessed that she was reluctant to take a GLP-1 drug as a result of she felt it was “the easy way out.” That modified after a particular on weight loss with consultants and clinicians that she taped in July 2023. The panel dialogue left her along with her “biggest aha moment” in regards to the treatment.

“I had an awareness of [weight-loss] medications [before], but felt I had to prove I had the willpower to do it. I now no longer feel that way,” she mentioned.

“I realized I’d been blaming myself all these years for being overweight, and I have a predisposition that no amount of willpower is going to control. Obesity is a disease. It’s not about willpower — it’s about the brain.”

Oprah Winfrey attends the 66th GRAMMY Awards at Crypto.com Arena on February 4, 2024 in Los Angeles, California. Getty Images for The Recording Academy

She continued, “This is a world that has shamed people for being overweight forever and all of us who have lived it know that people just treat you differently. They just do.”

“And I am Oprah Winfrey and I know all that comes with that and I get treated differently if I am 200 plus pounds versus under 200 pounds.”

Winfrey added, “There is a condescension. There is a stigma.”

We offer you the trending topics. Get the best newest Entertainment information and content material on our web site every day.

- Advertisement -
img
- Advertisement -

Latest News

- Advertisement -

More Related Content

- Advertisement -